Innovimmune Biotherapeutics Employee Directory
Biotechnology ResearchNew York, United States0-1 Employees
Innovimmune Biotherapeutics is a New York-based biotechnology research company pursuing discovery and early development of oral small molecule immunomodulators. Its focus is on proprietary compounds intended to modulate immune responses in autoimmune, inflammatory, and cancer indications. The company aims for first-in-class and best-in-class therapies and operates with a very small team. Recent activity includes presenting preclinical efficacy data at the European Society for Medical Oncology 2022 Congress on INV-71, a ROR gamma agonist, as both a single agent and in combination with anti-PD-1 in breast cancer. This demonstrates ongoing development of its immunomodulatory drug programs.